Avid Bioservices Inc (CDMO)

[biopharm]

Chris, thanks again I believe what causes frustration to some out there is that your article finally released some of the truth and the truth they don't want on this board. Thanks to your article, that sabotage is slowly coming to life to many retail investors that never realized of the potential that awaits behind PS Targeting.

------------------

"The case is currently two years underway in a CA central court; "Peregrine Pharmaceuticals Inc v. Clinical Supplies Management Inc" case (8:12-cv-01608) viewable on law360.com, gives savvy investors some insight into the alleged sabotage and intentional mis-labeling of bavituximab. Peregrine Pharmaceuticals is suing for damages of up to $2 billion. Peregrine Pharmaceuticals presumably had a deal with AbbVie Pharmaceuticals (NYSE:ABBV) in the summer of 2012 for royalties of up to $2 billion for partnering of bavituximab based on the Phase IIb trial results."

http://seekingalpha.com/article/2953756-wall-streets-current-play-immunotherapyofcancer?auth_param=pqq0:1aeuj2e:ae2bd5410d5d073f832d7d5fa027e920

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=111208370&txt2find=wall|street|play